Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 3
2003 2
2004 3
2005 6
2006 2
2007 2
2009 3
2010 2
2011 3
2012 1
2013 1
2015 3
2016 1
2017 1
2021 2
2022 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

35 results

Results by year

Filters applied: . Clear all
Page 1
Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial.
Rosell R, Carcereny E, Gervais R, Vergnenegre A, Massuti B, Felip E, Palmero R, Garcia-Gomez R, Pallares C, Sanchez JM, Porta R, Cobo M, Garrido P, Longo F, Moran T, Insa A, De Marinis F, Corre R, Bover I, Illiano A, Dansin E, de Castro J, Milella M, Reguart N, Altavilla G, Jimenez U, Provencio M, Moreno MA, Terrasa J, Muñoz-Langa J, Valdivia J, Isla D, Domine M, Molinier O, Mazieres J, Baize N, Garcia-Campelo R, Robinet G, Rodriguez-Abreu D, Lopez-Vivanco G, Gebbia V, Ferrera-Delgado L, Bombaron P, Bernabe R, Bearz A, Artal A, Cortesi E, Rolfo C, Sanchez-Ronco M, Drozdowskyj A, Queralt C, de Aguirre I, Ramirez JL, Sanchez JJ, Molina MA, Taron M, Paz-Ares L; Spanish Lung Cancer Group in collaboration with Groupe Français de Pneumo-Cancérologie and Associazione Italiana Oncologia Toracica. Rosell R, et al. Among authors: sanchez jm. Lancet Oncol. 2012 Mar;13(3):239-46. doi: 10.1016/S1470-2045(11)70393-X. Epub 2012 Jan 26. Lancet Oncol. 2012. PMID: 22285168 Clinical Trial.
Methylation patterns and chemosensitivity in NSCLC.
Ramírez JL, Salazar MF, Gupta J, Sánchez JM, Taron M, Sanchez-Ronco M, Alberola V, De las Peñas R. Ramírez JL, et al. Among authors: sanchez jm. Adv Exp Med Biol. 2006;587:195-209. doi: 10.1007/978-1-4020-5133-3_17. Adv Exp Med Biol. 2006. PMID: 17163167 Review.
Applications of genomics in NSCLC.
Rosell R, Cobo M, Isla D, Sanchez JM, Taron M, Altavilla G, Santarpia M, Moran T, Catot S, Etxaniz O. Rosell R, et al. Among authors: sanchez jm. Lung Cancer. 2005 Dec;50 Suppl 2:S33-40. Lung Cancer. 2005. PMID: 16557672 Review.
Predicting response to chemotherapy with early-stage lung cancer.
Rosell R, Taron M, Massuti B, Mederos N, Magri I, Santarpia M, Sanchez JM. Rosell R, et al. Among authors: sanchez jm. Cancer J. 2011 Jan-Feb;17(1):49-56. doi: 10.1097/PPO.0b013e3182091fa3. Cancer J. 2011. PMID: 21263267 Review.
Determinants of response and resistance to cytotoxics.
Rosell R, Monzó M, Alberola V, Taron M, Barnadas A, Sánchez JM, Manzano JL, Sanchez JJ. Rosell R, et al. Among authors: sanchez jm. Semin Oncol. 2002 Feb;29(1 Suppl 4):110-8. doi: 10.1053/sonc.2002.31532. Semin Oncol. 2002. PMID: 11894021 Review.
The promise of pharmacogenomics: gemcitabine and pemetrexed.
Rosell R, Taron M, Sanchez JM, Moran T, Reguart N, Besse B, Isla D, Massuti B, Alberola V, Sanchez JJ. Rosell R, et al. Among authors: sanchez jm. Oncology (Williston Park). 2004 Nov;18(13 Suppl 8):70-6. Oncology (Williston Park). 2004. PMID: 15655942 Free article. Review.
Role of heme oxygenase in the regulation of the renal hemodynamics in a model of sex-dependent programmed hypertension by maternal diabetes.
Martínez-Gascón LE, Ortiz MC, Galindo M, Sanchez JM, Sancho-Rodríguez N, Albaladejo-Otón MD, Rodríguez Mulero MD, Rodriguez F. Martínez-Gascón LE, et al. Among authors: sanchez jm. Am J Physiol Regul Integr Comp Physiol. 2022 Mar 1;322(3):R181-R191. doi: 10.1152/ajpregu.00213.2021. Epub 2022 Jan 5. Am J Physiol Regul Integr Comp Physiol. 2022. PMID: 34984919 Free article.
Author Correction: BIM and mTOR expression levels predict outcome to erlotinib in EGFR-mutant non-small-cell lung cancer.
Karachaliou N, Codony-Servat J, Teixidó C, Pilotto S, Drozdowskyj A, Codony-Servat C, Giménez-Capitán A, Molina-Vila MA, Bertrán-Alamillo J, Gervais R, Massuti B, Morán T, Majem M, Felip E, Carcereny E, García-Campelo R, Viteri S, González-Cao M, Morales-Espinosa D, Verlicchi A, Crisetti E, Chaib I, Santarpia M, Luis Ramírez J, Bosch-Barrera J, Felipe Cardona A, de Marinis F, López-Vivanco G, Miguel Sánchez J, Vergnenegre A, Sánchez Hernández JJ, Sperduti I, Bria E, Rosell R. Karachaliou N, et al. Among authors: miguel sanchez j. Sci Rep. 2023 Mar 3;13(1):3620. doi: 10.1038/s41598-023-30374-9. Sci Rep. 2023. PMID: 36869103 Free PMC article. No abstract available.
Pemetrexed in previously treated non-small-cell lung cancer.
Rosell R, Sanchez JM, Taron M, Moran T, Ciuraqui B, Canela M, Felip E, Massuti B, Camps C. Rosell R, et al. Among authors: sanchez jm. Oncology (Williston Park). 2004 Jul;18(8 Suppl 5):63-71. Oncology (Williston Park). 2004. PMID: 15339062 Review.
35 results